GNL Gut and Liver
  1. Anthony A. Sochet, Sorany Son, Kelsey S. Ryan, Meghan Roddy, Eddie Barrie, Michael Wilsey, Scott D. McKinley, Thomas A. Nakagawa. Stress ulcer prophylaxis in children with status asthmaticus receiving systemic corticosteroids: a descriptive study assessing frequency of clinically important bleeding. Journal of Asthma 2020;57:858
    https://doi.org/10.1080/02770903.2019.1614617
  2. Mai Alalawi, Seba Aljahdali, Bashaer Alharbi, Lana Fagih, Raghad Fatani, Ohoud Aljuhani. Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factors . Ann Saudi Med 2020;40:305
    https://doi.org/10.5144/0256-4947.2020.305
  3. Ivana Cibulková, Veronika Řehořová, Jan Hajer, František Duška. Fecal Microbial Transplantation in Critically Ill Patients—Structured Review and Perspectives. Biomolecules 2021;11:1459
    https://doi.org/10.3390/biom11101459
  4. Andreas M. Schneider, Brian E. Louie, Heather F. Warren, Alexander S. Farivar, Drew B. Schembre, Ralph W. Aye. A Matched Comparison of Per Oral Endoscopic Myotomy to Laparoscopic Heller Myotomy in the Treatment of Achalasia. Journal of Gastrointestinal Surgery 2016;20:1789
    https://doi.org/10.1007/s11605-016-3232-x
  5. Ajita S. Prabhu, David M. Krpata, Sharon Phillips, Li-Ching Huang, Ivy N. Haskins, Steven Rosenblatt, Benjamin K. Poulose, Michael J. Rosen. Preoperative Chlorhexidine Gluconate Use Can Increase Risk for Surgical Site Infections after Ventral Hernia Repair. 2017;224:334
    https://doi.org/10.1016/j.jamcollsurg.2016.12.013
  6. Megan Jaynes, Avinash B. Kumar. The risks of long-term use of proton pump inhibitors: a critical review. Therapeutic Advances in Drug Safety 2019;10:204209861880992
    https://doi.org/10.1177/2042098618809927
  7. Ewa Łoś-Rycharska, Mieczysława Czerwionka-Szaflarska. Inhibitory pompy protonowej a mikrobiom przewodu pokarmowego. Pediatria Polska 2017;92:238
    https://doi.org/10.1016/j.pepo.2016.12.011
  8. Tadayuki Oshima, Liping Wu, Min Li, Hirokazu Fukui, Jiro Watari, Hiroto Miwa. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. J Gastroenterol 2018;53:84
    https://doi.org/10.1007/s00535-017-1369-3
  9. M. Dietrich, C. J. Reuß, C. Beynon, A. Hecker, C. Jungk, D. Michalski, C. Nusshag, K. Schmidt, M. A. Weigand, M. Bernhard, T. Brenner. Additive Therapien. Anaesthesist 2020;69:52
    https://doi.org/10.1007/s00101-019-00642-3
  10. Nelson Javier Fonseca-Ruiz, Juan José Duque-Perez, Camilo Bello-Muñoz. «GASTELE UN DIA» a su paciente críticamente enfermo. Lista de chequeo en español para la atención de calidad en cuidado intensivo. Acta Colombiana de Cuidado Intensivo 2024;24:45
    https://doi.org/10.1016/j.acci.2023.10.001
  11. Chen Chen, Hui Liu, Ruqiao Duan, Fangfang Wang, Liping Duan. The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients. J of Gastro and Hepatol 2021;36:2131
    https://doi.org/10.1111/jgh.15432
  12. Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clin Drug Investig 2017;37:587
    https://doi.org/10.1007/s40261-017-0519-y
  13. Jeffrey K. Aronson. Inhibiting the proton pump: mechanisms, benefits, harms, and questions. BMC Med 2016;14
    https://doi.org/10.1186/s12916-016-0724-1
  14. Dmitriy Viderman, Alpamys Issanov, Talgat Temirov, Ewan Goligher, Philip la Fleur. Outcome Predictors of Stroke Mortality in the Neurocritical Care Unit. Front. Neurol. 2020;11
    https://doi.org/10.3389/fneur.2020.579733
  15. Parisa Ghasemiyeh, Soliman Mohammadi-Samani, Negar Firouzabadi, Afsaneh Vazin, Farid Zand. A brief ICU residents’ guide: Pharmacotherapy, pharmacokinetic aspects and dose adjustments in critically ill adult patients admitted to ICU. Trends in Anaesthesia and Critical Care 2021;41:11
    https://doi.org/10.1016/j.tacc.2021.05.004
  16. Anca Trifan, Carol Stanciu, Irina Girleanu, Oana Cristina Stoica, Ana Maria Singeap, Roxana Maxim, Stefan Andrei Chiriac, Alin Ciobica, Lucian Boiculese. Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis. WJG 2017;23:6500
    https://doi.org/10.3748/wjg.v23.i35.6500
  17. Adis Medical Writers. Use acid-suppressing drugs appropriately with an individualized approach to minimize the risk of infection. Drugs Ther Perspect 2018;34:67
    https://doi.org/10.1007/s40267-017-0473-z
  18. Massimo Antonelli, Ignacio Martin-Loeches, George Dimopoulos, Antonio Gasbarrini, Maria Sole Vallecoccia. Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement. Intensive Care Med 2020;46:215
    https://doi.org/10.1007/s00134-019-05873-x
  19. Carmelo Scarpignato, Luigi Gatta, Angelo Zullo, Corrado Blandizzi. Effective and safe proton pump inhibitor therapy in acid-related diseases – A position paper addressing benefits and potential harms of acid suppression. BMC Med 2016;14
    https://doi.org/10.1186/s12916-016-0718-z
  20. Alexa Rae Roberts, Meghan Roddy, Michael John Wilsey, Scott Daniel McKinley, Beatriz Sanchez-Teppa, Anthony Alexander Sochet. Stress Ulcer Prophylaxis for Critical Asthma. 2022;149
    https://doi.org/10.1542/peds.2021-054527
  21. Richard R. Watkins, Caroline Mangira, Farid Muakkassa, Curtis J. Donskey, Nairmeen A. Haller. Clostridium difficileInfection in Trauma, Surgery, and Medical Patients Admitted to the Intensive Care Unit. Surgical Infections 2018;19:488
    https://doi.org/10.1089/sur.2017.253
  22. Beth Burgwyn Fuchs, Nagendran Tharmalingam, Eleftherios Mylonakis. Vulnerability of Long-Term Care Facility Residents to Clostridium Difficile Infection Due to Microbiome Disruptions . Future Microbiol. 2018;13:1537
    https://doi.org/10.2217/fmb-2018-0157
  23. Mohamed Azab, Loomee Doo, Daniel H. Doo, Yousif Elmofti, Muazer Ahmed, John Jay Cadavona, Xibei B. Liu, Amaan Shafi, Moon Kyung Joo, Ji Won Yoo. Comparison of the Hospital-AcquiredClostridium difficileInfection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis. Gut and Liver 2017;11:781
    https://doi.org/10.5009/gnl16568
  24. Jessica S. Tischendorf, Mary J. Knobloch, Jackson S. Musuuza, Nasia Safdar. Using a Systems Engineering Framework to Evaluate Proton Pump Inhibitor Prescribing in Critically Ill Patients. J Healthc Qual 2020;42:e39
    https://doi.org/10.1097/JHQ.0000000000000209
  25. Paul M. Reynolds, Lauren Wells, Marissa Powell, Robert MacLaren. Associated Mortality Risk of Proton Pump Inhibitor Therapy for the Prevention of Stress Ulceration in Intensive Care Unit Patients. 2023;57:586
    https://doi.org/10.1097/MCG.0000000000001723
  26. Shaden S Alhujilan, Mustafa S Saeed, Abdullah Abdulaziz Alalwan. Assessment of adherence to the national stress ulcer prophylaxis guidelines: A cross-sectional analysis. Saudi Pharmaceutical Journal 2023;31:101754
    https://doi.org/10.1016/j.jsps.2023.101754
  27. Jung Hwa Min, You Sun Kim. Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection. Gut and Liver 2016;10:493
    https://doi.org/10.5009/gnl16216
  28. F. Cao, C.X. Chen, M. Wang, H.R. Liao, M.X. Wang, S.Z. Hua, B. Huang, Y. Xiong, J.Y. Zhang, Y.L. Xu. Updated meta-analysis of controlled observational studies: proton-pump inhibitors and risk of Clostridium difficile infection. Journal of Hospital Infection 2018;98:4
    https://doi.org/10.1016/j.jhin.2017.08.017
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd